Platelet membrane phospholipid asymmetry: From the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 10, 2011, Pages 1883-1891

  Lhermusier, T ^a   Chap, H ^b   Payrastre, B ^a,c  

^a University Hospital of Toulouse   (France)

^b INSERM   (France)

^c Hôpital de Toulouse   (France)

Author keywords

Phosphatidylserine; Phospholipid asymmetry; Platelet procoagulant activity; Scott syndrome; Scramblase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMINOPHOSPHOLIPID; CALCIUM; CALPAIN; CARRIER PROTEIN; CHOLINE; COLLAGEN; COMPLEMENTARY DNA; FLIPPASE; FLOPPASE; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; SCRAMBLASE; THROMBIN; THROMBOPLASTIN; TMEM16F PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; UNCLASSIFIED DRUG;

APOPTOSIS; BLOOD CLOTTING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CHROMOSOME 12; CODON; CYTOLYSIS; CYTOSKELETON; CYTOSOL; ENZYME ACTIVITY; GENE LOCATION; HEMOSTASIS; HUMAN; INTRON; LIPID RAFT; LIPID TRANSPORT; MEMBRANE DAMAGE; MEMBRANE MICROPARTICLE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SCOTT SYNDROME; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

APOPTOSIS; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; CALCIUM; HUMANS; MEMBRANE LIPIDS; MUTATION; PHOSPHOLIPID TRANSFER PROTEINS; PLATELET ACTIVATION; SYNDROME;

EID: 80053429773     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04478.x     Document Type: Review

References (81)

1. Bretscher MS. Asymmetrical lipid bilayer structure for biological membranes. Nature (New Biol) 1972; 236: 11-2.
2. Schick PK, Kurica KB, Chacko GK. Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest 1976; 57: 1221-6.
3. Verkleij AJ, Zwaal RFA, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LLM. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 1973; 323: 178-93.
4. Chap HJ, Zwaal RFA, van Deenen LL. Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta 1977; 467: 146-64.
5. Perret B, Chap HJ, Douste-Blazy L. Asymmetric distribution of arachidonic acid in the plasma membrane of human platelets. A determination using purified phospholipases and a rapid method for membrane isolation. Biochim Biophys Acta 1979; 556: 434-46.
6. Berridge MJ. Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 2009; 793: 933-40.
7. Nakamura S, Yamamura H. Yasutomi Nishizuka: father of protein kinase C. J Biochem 2010; 148: 125-30.
8. Plantavid M, Perret BP, Chap H, Simon MF, Douste-Blazy L. Asymmetry of arachidonic acid metabolism in the phospholipids of the human platelet membrane as studied with purified phospholipases. Biochim Biophys Acta 1982; 693: 451-60.
9. Gratacap M-P, Martin V, Guillermet-Guibert J, Chicanne G, Payrastre B. PI 3-kinase β in the regulation of platelet signalling and functions. Adv Enz Reg 2011; 51: 106-16.
10. Zwaal RFA, Comfurius P, van Deenen LLM. Membrane asymmetry and blood coagulation. Nature 1977; 268: 358-60.
11. Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468: 834-8.
12. Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RFA. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
13. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
14. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
15. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 2005; 3: 2185-92.
16. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA 1984; 81: 3751-5.
17. Daleke DL. Regulation of transbilayer plasma membrane phospholipids asymmetry. J Lipid Res 2003; 44: 233-42.
18. Zwaal RFA, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 971-88.
19. Tang X, Halleck MS, Schlegel RA, Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 1996; 272: 1495-7.
20. Paulusma CC, Elferink RP. P4 ATPases - The physiological relevance of lipid flipping transporters. FEBS Lett 2010; 584: 2708-16.
21. Kamp D, Haest CWM. Evidence for a role of multidrug resistance protein (MRP) in outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim Biophys Acta 1998; 1372: 91-101.
22. Dekkers DWC, Comfurius P, Schroit AJ, Bevers EM, Zwaal RFA. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes; outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 1998; 37: 14833-7.
23. Lieke M, van der Velden L, van de Graaf SFJ, Klomp LWJ. Biochemical and cellular functions of P4 ATPases. Biochem J 2010; 431: 1-11.
24. DeGorter MK, Conseil GI, Deeley RG, Campbell RL, Cole SPC. Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochem Biophys Res Commun 2008; 365: 29-34.
25. He SM, Li R, Kanwar JR, Zhou SF. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr Med Chem 2011; 18: 439-81.
26. Bevers EM, Williamson PL. Phospholipid scramblase: an update. FEBS Lett 2010; 584: 2724-30.
27. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979; 67: 206-13.
28. Rosing J, Bevers EM, Comfurius P, Hemker HC, van Dieijen G, Weiss HJ, Zwaal RFA. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 1985; 65: 1557-61.
29. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992; 79: 380-8.
30. Williamson P, Christie A, Kohlin T, Schlegel RA, Comfurius P, Harmsma M, Zwaal RFA, Bevers EM. Phospholipid scramblase activation pathways in lymphocytes. Biochemistry 2001; 40: 8065-72.
31. Satta N, Toti F, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets 1997; 8: 117-24.
32. Zwaal RFA, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004; 1636: 119-28.
33. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic disorder. Blood 1996; 87: 1409-15.
34. Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002; 99: 2434-41.
35. Zwaal RFA, Schroit AJ. Pathophysiologic implication of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
36. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-601.
37. Fadok VA, Voelker D, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-16.
38. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-20.
39. Freyssinet JM, Torti F. Formation of procoagulant microparticles and properties. Thromb Res 2010; 125: S46-8.
40. Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry 1995; 34: 11625-34.
41. Fourcade O, Simon MF, Viodé C, Rugani FL, Ragab A, Fournie B, Sarda L, Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995; 80: 919-27.
42. Barry OP, Praticò D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-27.
43. 2 to liberate arachidonic acid. Biochim Biophys Acta 1997; 1349: 43-54.
44. 2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 2006; 281: 775-81.
45. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-9.
46. Weiss HJ. Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin Thromb Hemost 2009; 35: 233-41.
47. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
48. Krishnaswamy S, Church WR, Nesheim ME, Mann KG. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987; 262: 3291-9.
49. Nesheim ME, Mann KG. The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation. J Biol Chem 1983; 258: 5386-91.
50. Boskovic DS, Bajzar LS, Nesheim ME. Channeling during prothrombin activation. J Biol Chem 2001; 276: 28686-93.
51. Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-32.
52. Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272: 9244-51.
53. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
54. Bevers EM, Rosing J, Zwaal RF. Development of procoagulant binding sites on the platelet surface. Adv Exp Med Biol 1985; 192: 359-71.
55. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
56. Husten EJ, Esmon CT, Johnson AE. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem 1987; 262: 12953-61.
57. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
58. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RF. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995; 34: 10448-55.
59. Kunzelmann-Marche C, Freyssinet JM, Martinez MC. Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry: role of actin cytoskeleton. J Biol Chem 2001; 276: 5134-9.
60. Martinez MC, Martin S, Toti F, Fressinaud E, Dachary-Prigent J, Meyer D, Freyssinet JM. Significance of capacitative Ca2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry 1999; 38: 10092-8.
61. Kunzelmann-Marche C, Freyssinet JM, Martinez MC. Loss of plasma membrane phospholipids asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway. J Biol Chem 2002; 277: 19876-81.
62. Bergmeier W, Oh-hora M, McCarl C-A, Roden RC, Bray PF, Feske S. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009; 113: 675-8.
63. Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MAH, Stegner D, van der Meijden PEJ, Kuijpers MJE, Varga-Szabo D, Heemskerk JWM, Nieswandt B. Role of platelet STIM1 and Orai 1 in glycoporotein VI-and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 2010; 285: 23629-38.
64. Comfurius P, Bevers EM, Zwaal RFA. The involvement of cytoskeleton in the regulation of transbilayer movement of phospholipids in human blood platelets. Biochim Biophys Acta 1985; 815: 143-8.
65. Fox JEB, Reynolds CC, Austin CD. The role of calpain in stimulus-response coupling evidence that calpain mediates agonist-induced expression of procoagulant activity in platelets. Blood 1990; 12: 2510-9.
66. Siljander P, Farndale RW, Feijge MAH, Comfurius P, Kos S, Bevers EM, Heemskerk JWM. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response, involvement of p38MAP Kinase and calpain. Arterioscler Thromb Vasc Biol 2001; 21: 618-27.
67. Ravanat C, Strassel C, Hechler B, Schuhler S, Chicanne G, Payrastre B, Gachet C, Lanza F. A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbalpha N-terminal extracellular domain. Blood 2010; 116: 1157-64.
68. Martin DW, Jesty J. Calcium stimulation of procoagulant activity in human erythrocytes. J Biol Chem 1995; 270: 10468-74.
69. Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD, O'Reilly LA, Henley KJ, Ono A, Hsiao S, Willcox A, Roberts AW, Huang DC, Salem HH, Kile BT, Jackson SP. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-6.
70. Dasgupta SK, Abdel-Monem H, Niravath P, Le A, Bellera RV, Langlois K, Nagata S, Rumbaut RE, Thiagarajan P. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009; 113: 1332-9.
71. Albrecht C, McVey JH, Elliott JI, Sardini A, Kasza I, Mumford AD, Naoumova RP, Tuddenham EG, Szabo K, Higgins CF. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood 2005; 106: 542-9.
72. Williamson P, Halleck MS, Malowitz J, Ng S, Fan X, Krahling S, Remaley AT, Schlegel RA. Transbilayer phospholipid movements in ABCA1-deficient cells. PLoS ONE 2007; 2: e729.
73. Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998; 92: 1707-12.
74. Zhou Q, Zhao J, Wiedmer T, Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipids scramblase 1. Blood 2002; 99: 4030-8.
75. Castoldi E, Collins PW, Williamson PL, Bevers EM. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 2011; 117: 4399-400.
76. Munnix IC, Harmsma M, Gidding JC, Collins PW, Feijge MA, Comfurius P, Heemskerk JW, Bevers EM. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003; 89: 687-95.
77. Brooks M, Etter K, Catalfamo J, Brisbin A, Bustamante C, Mezey J. A genome-wide linkage scan in German shepherd dogs localizes canine platelet procoagulant deficiency (Scott syndrome) to canine chromosome 27. Gene 2010; 450: 70-5.
78. Galietta LJV. The TMEM16 protein family a new class of chloride channels? Biophys J 2009; 97: 3047-53.
79. Duran Cn Hartzell HC. Physiological roles and diseases of tmem16/anoctamin proteins: are they all chloride channels? Acta Pharmacol Sin 2011; 32: 685-92.
80. Menon I, Huber T, Sanyal S, Banerjee S, Barré P, Canis S, Warren JD, Hwa J, Sakmar TP, Menon AK. Opsin is a phospholipid flippase. Curr Biol 2011; 21: 149-53.
81. Williamson P. Phospholipid transport: sighting a new face of an old friend. Curr Biol 2011; 21: R168-9.